CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 46 enrolled
Drug / intervention
Receive ICBN with ropivacaine +1 moredrug
Likely dose
Receive ICBN with ropivacaine 10 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03797924
NCT03797924Early Ph 1Completed
CompareCT.gov

Intercostobrachial Nerve Block (ICBN) for Tourniquet Pain: Is it Necessary?

University of Florida·interventional·Posted Jan 9, 2019·Updated May 24, 2022

In Brief

A Early Phase 1 clinical trial evaluating Receive ICBN with ropivacaine and No ICBN block for Nerve Block and Pain. Completed, enrolled 46 participants across 1 site.

Detailed Summary

In this study the investigators would like to show that when patients undergo upper limb surgery under supraclavicular brachial plexus block, additional blocking of the Intercostobrachial Nerve Block (ICBN) does not affect the incidence or course of tourniquet pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNerve Block, Pain
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
20192020202120222023202420252026
First PostedJan 9, 2019
Enrollment StartApr 25, 2019
Primary CompletionDec 20, 2020
Study CompletionDec 13, 2021
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 7.5 years ago

Interventions

Receive ICBN with ropivacainedrug

ICBN block will be performed using US guidance depositing 10 ml of 0.5% ropivacaine in the plane between pectoralis minor and serratus anterior over the 2nd and 3rd intercostal space.

No ICBN blockbehavioral

The site of injection will be prepped with tinted chlorhexidine